Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data.
about
A new therapeutic option for postoperative pain management with oxycodone HCI injectionPharmacogenetics of healthy volunteers in Puerto RicoClinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotypeClinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.Maribavir pharmacokinetics and the effects of multiple-dose maribavir on cytochrome P450 (CYP) 1A2, CYP 2C9, CYP 2C19, CYP 2D6, CYP 3A, N-acetyltransferase-2, and xanthine oxidase activities in healthy adultsIdentification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African AmericansAssociation between genetic polymorphisms of CYP2D6 and outcomes in breast cancer patients with tamoxifen treatmentClinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexiline.The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis.Allelic and genotype frequencies of catechol-O-methyltransferase (Val158Met) and CYP2D6*10 (Pro34Ser) single nucleotide polymorphisms in the Philippines.The role of pharmacogenetics in cancer therapeutics.Evaluation of a [13C]-dextromethorphan breath test to assess CYP2D6 phenotype.Genetic determinants of variable metabolism have little impact on the clinical use of leading antipsychotics in the CATIE study.Population pharmacokinetic/pharmacodynamic modelling of the effects of axomadol and its O-demethyl metabolite on pupil diameter and nociception in healthy subjectsPharmacokinetic interaction of flecainide and paroxetine in relation to the CYP2D6*10 allele in healthy Korean subjectsFrequencies of Functional Polymorphisms in Three Pharmacokinetic Genes of Clinical Interest within the Admixed Puerto Rican PopulationPopulation pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients.Cytochrome P450 2D6.Pharmacogenetics informed decision making in adolescent psychiatric treatment: a clinical case report.Relationship between cytochrome P450 polymorphisms and prescribed medication in elderly haemodialysis patients.CYP2D6 allele distribution in Macedonians, Albanians and Romanies in the Republic of Macedonia.Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines.Identification of Novel CYP2D7-2D6 Hybrids: Non-Functional and Functional Variants.The effect of CYP2D6 *10 polymorphism on adjuvant tamoxifen in Asian breast cancer patients: a meta-analysis.
P2860
Q26747676-E368C910-E25B-475D-AC7C-56D8E562570AQ26779038-29566FD6-4F78-429E-AC0E-A119E64CEE67Q34243414-8E7E9E32-B74F-482E-A9DC-264BAA508270Q34399802-CD736FE2-D44A-417A-A408-0036133115F2Q34510611-0D86CA61-041D-452F-9AF4-E956820F2960Q34546846-7F827B9C-C8FF-46FB-81E5-1B75C1052B1CQ35158757-49932744-E747-4F4F-8FB0-B195C28B007CQ35826004-9F49260B-36E6-4A24-9247-A11B53196626Q35994975-DA211870-90D9-4EFD-9F69-60FAB254B277Q36038272-89D5F78D-B49E-41AE-A150-7B23435C716BQ36536674-6C16CB45-4D72-49D3-8ABB-5358B31734EAQ36684887-5A376291-B7B5-490D-B605-1CF41D78FC30Q36969067-CE72395C-66C1-42B3-92BA-A74F4B7EA293Q37030723-B8DABBC0-B798-4BB6-9B08-DBE07276F85EQ37142440-FDA16885-C188-428B-BA63-9824B7228276Q37162200-5B2E0782-000A-4D3A-AA09-97708B678E6FQ37175786-F01D2BB4-3BCD-49EA-8C90-0636A2B6BFE6Q37513508-FBE38A9B-2F4D-4262-97DC-FF6CECF2E739Q39035865-09307966-5716-43B5-A031-504C5870FF1AQ39295178-835D4501-B0A8-46CB-8C12-3330E7BA89F8Q41110398-0D89378F-BEC4-4379-A394-8CCCC4002D33Q42335970-64FE0816-828E-4908-B1B5-09419C7A5B50Q42727745-462FB90E-D72A-4CAA-9266-6CE163C7787FQ45987663-901C82BE-74C8-45EA-9C59-CEC2F9C2BC79
P2860
Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Optimization of cytochrome P45 ...... ased on allele frequency data.
@ast
Optimization of cytochrome P45 ...... ased on allele frequency data.
@en
type
label
Optimization of cytochrome P45 ...... ased on allele frequency data.
@ast
Optimization of cytochrome P45 ...... ased on allele frequency data.
@en
prefLabel
Optimization of cytochrome P45 ...... ased on allele frequency data.
@ast
Optimization of cytochrome P45 ...... ased on allele frequency data.
@en
P2093
P1476
Optimization of cytochrome P45 ...... ased on allele frequency data.
@en
P2093
P304
P577
1999-12-01T00:00:00Z